Innovative Hangover Remedy Introduced to Domestic Market

Published: 2004-12-06 06:57:00

Updated: 2004-12-06 06:57:00

Giyoung Pharmaceuticals has received an exclusive marketing right for sale and distribution of Korea B.B.K. Plus’s innovative tablet-type hangover remedy, PaliPali.

Korea B.B.K. Plus is a domestic arm of the multinational B.B.K. Plus Corporation. The remedy, PaliPali, was researched and devel...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK